MyoKardia, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced operating loss was USD 85.403 million compared to USD 145.118 million a year ago. Net loss was USD 84.744 million compared to USD 141.802 million a year ago. Basic loss per share from continuing operations was USD 1.6 compared to USD 3.07 a year ago. For the nine months, operating loss was USD 221.768 million compared to USD 226.423 million a year ago. Net loss was USD 218.197 million compared to USD 217.446 million a year ago. Basic loss per share from continuing operations was USD 4.38 compared to USD 4.91 a year ago.